Wu, Y. Et Al. 2020. Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer. NEW ENGLAND JOURNAL OF MEDICINE , vol.383, no.18 , 1711-1723.

Wu, Y., Tsuboi, M., He, J., John, T., Grohe, C., Majem, M., ... Goldman, J. W.(2020). Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer. NEW ENGLAND JOURNAL OF MEDICINE , vol.383, no.18, 1711-1723.

Wu, ERDEM Et Al. "Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer," NEW ENGLAND JOURNAL OF MEDICINE , vol.383, no.18, 1711-1723, 2020

Wu, ERDEM Et Al. "Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer." NEW ENGLAND JOURNAL OF MEDICINE , vol.383, no.18, pp.1711-1723, 2020

Wu, Y. Et Al. (2020) . "Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer." NEW ENGLAND JOURNAL OF MEDICINE , vol.383, no.18, pp.1711-1723.

@article{article, author={ERDEM ÇUBUKÇU Et Al. }, title={Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2020, pages={1711-1723} }